LIPE and Other metabolic disease: Our findings demonstrated that sesamol decreased the expression of SREBP-1c and increased the expressions of p-HSL, PGC1α, and CPT1α, which promoted lipid metabolism in the liver to ameliorate obesity and obesity-associated metabolic disorders.